首页 > 最新文献

中华心血管病杂志最新文献

英文 中文
[A 50-year review of Chinese Journal of Cardiology and cardiac arrhythmia research in China]. 【《中国心脏病学杂志》与中国心律失常研究50年综述】。
Q3 Medicine
中华心血管病杂志
Pub Date : 2023-10-24 DOI: 10.3760/cma.j.cn112148-20230607-00334
J Wang, S Zuo, C S Ma
随着电生理理论的完善、设备技术的革新和临床科研经验的积累，我国的心律失常领域取得了长足进步。《中华心血管病杂志》自1972年创刊、1973年正式出版以来，至今已走过50年，与我国心血管病学共同发展，见证了心律失常专业逐渐由追赶者发展为领先者。本文将结合《中华心血管病杂志》发表的文章，从心律失常的流行病学、诊断治疗、临床研究、诊疗管理及教育培训等诸多方面，介绍中国心律失常发展的概况，回顾取得的重要研究成果。.
{"title":"[A 50-year review of Chinese Journal of Cardiology and cardiac arrhythmia research in China].","authors":"J Wang, S Zuo, C S Ma","doi":"10.3760/cma.j.cn112148-20230607-00334","DOIUrl":"10.3760/cma.j.cn112148-20230607-00334","url":null,"abstract":"随着电生理理论的完善、设备技术的革新和临床科研经验的积累，我国的心律失常领域取得了长足进步。《中华心血管病杂志》自1972年创刊、1973年正式出版以来，至今已走过50年，与我国心血管病学共同发展，见证了心律失常专业逐渐由追赶者发展为领先者。本文将结合《中华心血管病杂志》发表的文章，从心律失常的流行病学、诊断治疗、临床研究、诊疗管理及教育培训等诸多方面，介绍中国心律失常发展的概况，回顾取得的重要研究成果。.","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"51 10","pages":"1015-1021"},"PeriodicalIF":0.0,"publicationDate":"2023-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49683197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Simultaneous transcatheter aortic valve replacement and mitral balloon dilatation in patients with severe aortic stenosis and mitral stenosis: two case reports]. [同时经导管主动脉瓣置换术和二尖瓣球囊扩张治疗严重主动脉瓣狭窄和二尖瓣狭窄患者：两例报告]。
Q3 Medicine
中华心血管病杂志
Pub Date : 2023-10-24 DOI: 10.3760/cma.j.cn112148-20230808-00062
H J Dong, R Wang, X Wang, J Liu, B Z X Pu, J Li, Y J Mo, M Fu, G Li, J F Luo
主动脉狭窄（AS）合并二尖瓣狭窄（MS）多见于风湿性心脏病，传统治疗策略为外科手术，但外科手术高风险的严重AS合并MS患者通常难以耐受开放性手术，随着介入技术的发展，同期经导管治疗为其提供了一种新的选择。该文报道了2例行经导管主动脉瓣置换术联合经皮二尖瓣球囊成形术治疗AS合并MS的病例，2例患者的主动脉瓣及二尖瓣狭窄均得到了有效缓解，术后心功能明显改善，未出现严重并发症。.
{"title":"[Simultaneous transcatheter aortic valve replacement and mitral balloon dilatation in patients with severe aortic stenosis and mitral stenosis: two case reports].","authors":"H J Dong, R Wang, X Wang, J Liu, B Z X Pu, J Li, Y J Mo, M Fu, G Li, J F Luo","doi":"10.3760/cma.j.cn112148-20230808-00062","DOIUrl":"10.3760/cma.j.cn112148-20230808-00062","url":null,"abstract":"主动脉狭窄（AS）合并二尖瓣狭窄（MS）多见于风湿性心脏病，传统治疗策略为外科手术，但外科手术高风险的严重AS合并MS患者通常难以耐受开放性手术，随着介入技术的发展，同期经导管治疗为其提供了一种新的选择。该文报道了2例行经导管主动脉瓣置换术联合经皮二尖瓣球囊成形术治疗AS合并MS的病例，2例患者的主动脉瓣及二尖瓣狭窄均得到了有效缓解，术后心功能明显改善，未出现严重并发症。.","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"51 10","pages":"1082-1086"},"PeriodicalIF":0.0,"publicationDate":"2023-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49683255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Chinese expert consensus on perioperative cardiovascular assessment and management of patients undergoing non-cardiac surgery]. [中国非心脏手术患者围手术期心血管评估与管理专家共识]。
Q3 Medicine
中华心血管病杂志
Pub Date : 2023-10-24 DOI: 10.3760/cma.j.cn112148-20221111-00883
大量接受非心脏外科手术的患者合并心血管疾病或存在心血管疾病危险因素。这些患者在围手术期需要接受心血管事件风险评估，合并明确心血管疾病的患者还需要评估手术时机以及调整目前使用的心血管药物，以尽可能减少围手术期发生心血管事件的风险。同时，非心脏外科手术围手术期的心血管疾病管理还要避免过度检查提高医疗成本，以及避免过度推迟非心脏外科手术从而影响患者预后。近年来，国际上针对非心脏外科手术围手术期心血管疾病管理更新了临床指南/专家共识，而我国尚缺乏相应的指南或共识。该共识基于目前已有的循证医学证据，结合国内外指南及国内的医疗资源现状，着眼于解决上述问题，为心血管专科及外科医师提供具备实用性的诊疗管理方案。.
{"title":"[Chinese expert consensus on perioperative cardiovascular assessment and management of patients undergoing non-cardiac surgery].","authors":"","doi":"10.3760/cma.j.cn112148-20221111-00883","DOIUrl":"10.3760/cma.j.cn112148-20221111-00883","url":null,"abstract":"大量接受非心脏外科手术的患者合并心血管疾病或存在心血管疾病危险因素。这些患者在围手术期需要接受心血管事件风险评估，合并明确心血管疾病的患者还需要评估手术时机以及调整目前使用的心血管药物，以尽可能减少围手术期发生心血管事件的风险。同时，非心脏外科手术围手术期的心血管疾病管理还要避免过度检查提高医疗成本，以及避免过度推迟非心脏外科手术从而影响患者预后。近年来，国际上针对非心脏外科手术围手术期心血管疾病管理更新了临床指南/专家共识，而我国尚缺乏相应的指南或共识。该共识基于目前已有的循证医学证据，结合国内外指南及国内的医疗资源现状，着眼于解决上述问题，为心血管专科及外科医师提供具备实用性的诊疗管理方案。.","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"51 10","pages":"1043-1055"},"PeriodicalIF":0.0,"publicationDate":"2023-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49683201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Research progress on molecular targets and results of targeted interventions of vascular aging]. 【血管衰老分子靶点及靶向干预结果研究进展】。
Q3 Medicine
中华心血管病杂志
Pub Date : 2023-10-24 DOI: 10.3760/cma.j.cn112148-20230530-00317
W W Zhang, F Cao
血管衰老是血管壁结构和功能随年龄增长逐渐退化损伤的过程，可增加心血管疾病的风险。本文系统回顾了血管衰老的分子机制，从DNA损伤应答、细胞周期阻滞、衰老相关分泌表型、线粒体功能障碍以及代谢紊乱等方面，介绍了血管衰老分子干预靶点的研究进展，展望了延缓血管衰老的潜在策略，旨在为血管衰老的防控提供帮助。.
{"title":"[Research progress on molecular targets and results of targeted interventions of vascular aging].","authors":"W W Zhang, F Cao","doi":"10.3760/cma.j.cn112148-20230530-00317","DOIUrl":"10.3760/cma.j.cn112148-20230530-00317","url":null,"abstract":"血管衰老是血管壁结构和功能随年龄增长逐渐退化损伤的过程，可增加心血管疾病的风险。本文系统回顾了血管衰老的分子机制，从DNA损伤应答、细胞周期阻滞、衰老相关分泌表型、线粒体功能障碍以及代谢紊乱等方面，介绍了血管衰老分子干预靶点的研究进展，展望了延缓血管衰老的潜在策略，旨在为血管衰老的防控提供帮助。.","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"51 10","pages":"1104-1108"},"PeriodicalIF":0.0,"publicationDate":"2023-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49683252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Research status and progress of cardiovascular magnetic resonance molecular imaging]. 【心血管磁共振分子成像研究现状与进展】。
Q3 Medicine
中华心血管病杂志
Pub Date : 2023-10-24 DOI: 10.3760/cma.j.cn112148-20230807-00057
Y Tang, X Ma, S H Zhao
在心血管影像发展中，磁共振多模态成像技术具备在体评估心肌组织学特征的优势，有较高的临床应用价值，其“一站式”成像在心血管疾病诊断、鉴别诊断以及预后判断和危险分层中发挥了重要作用，其在分子影像学领域也在不断发展。该文从动脉粥样硬化、心肌梗死、干细胞疗法3个方面介绍磁共振分子探针及其成像技术的应用。.
{"title":"[Research status and progress of cardiovascular magnetic resonance molecular imaging].","authors":"Y Tang, X Ma, S H Zhao","doi":"10.3760/cma.j.cn112148-20230807-00057","DOIUrl":"10.3760/cma.j.cn112148-20230807-00057","url":null,"abstract":"在心血管影像发展中，磁共振多模态成像技术具备在体评估心肌组织学特征的优势，有较高的临床应用价值，其“一站式”成像在心血管疾病诊断、鉴别诊断以及预后判断和危险分层中发挥了重要作用，其在分子影像学领域也在不断发展。该文从动脉粥样硬化、心肌梗死、干细胞疗法3个方面介绍磁共振分子探针及其成像技术的应用。.","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"51 10","pages":"1090-1097"},"PeriodicalIF":0.0,"publicationDate":"2023-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49683253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Screening for asymptomatic atrial fibrillation in elder community populations in Dalian: a single center study]. [大连市老年社区人群无症状心房颤动筛查：一项单中心研究]。
Q3 Medicine
中华心血管病杂志
Pub Date : 2023-10-24 DOI: 10.3760/cma.j.cn112148-20230819-00097
Y H Yang, R Q Xu, R F Zhang, Y S Wei, L Hong, J Sun, T Cong, Y L Xia

Objective: We aimed to determine the epidemiological characteristics of asymptomatic AF in elder community population (≥65 years old) to analyze the detection rate of different screening methods. Methods: The study was a prospective cohort study. The elder (≥65 years old) residents who voluntarily participated in free physical examination in Dalian community were selected. The participants were randomly divided into screening group (including intensive screening group and single screening group) and control group. The control group received interrogation, medical history collection and routine 12-lead electrocardiogram (ECG) examination. Screening group received an additional single-lead ambulatory ECG equipment worn for 5-7 days. Intensive screening group received two equal-length wearings in 2020 and 2021 respectively, while one screening group only wore once in 2020. Results: Finally 3 340 residents ((70.7±5.0) years old) which consisted of 1 488 males (44.55%) were enrolled. There were 1 945 residents in screening group, including 859 in intensive screening group and 1 086 in one-time screening group. The control group included 1 395 people. Detection rate of asymptomatic AF was significantly higher in screening group than control group (79(4.06%) vs. 24(1.72%), P<0.001). Higher detection rate was found in screening group than control group in AF risk factors (1 or 2-3) subgroups and CHA2DS2-VASc score (2-3 or≥4) subgroups (P<0.05). Additionally, no difference was found between intensive screening group and single screening group (42(4.89%) vs. 37(3.41%), P=0.100). Intensive screening increased detection rate (7(6.93%) vs. 1(0.58%), P=0.009) only in residents those with low thrombosis risk (CHA2DS2-VaSc<2). Conclusions: Screening in elderly (≥65 years old) can significantly improve the detection rate of asymptomatic AF by wearing single lead dynamic ECG device. The rate increased significantly with the increase of risk factors associated with AF by single screening. In addition, repeat screening of the same method may only improve detection rates in the group with low risk thrombotic scores and non-combination of AF risk factors.Screening methods that are appropriate for different populations may require further exploration.

目的：了解社区老年人群（≥65岁）无症状房颤的流行病学特征，分析不同筛查方法的检出率。方法：本研究为前瞻性队列研究。选取大连社区自愿参加免费体检的老年（≥65岁）居民。参与者被随机分为筛查组（包括强化筛查组和单次筛查组）和对照组。对照组接受询问、病史采集和常规12导联心电图检查。筛查组接受额外的单导联动态心电图设备，佩戴5-7天。强化筛查组分别在2020年和2021年接受了两次等长的穿着，而一个筛查组在2020年只穿了一次。结果：最终登记了3340名居民（70.7±5.0）岁，其中男性1488人（44.55%）。筛查组居民1 945人，其中强化筛查组859人，一次性筛查组1 086人。对照组包括1395人。筛查组无症状性房颤检出率显著高于对照组（79（4.06%）vs.24（1.72%），P0.001）。房颤危险因素（1或2-3）亚组和CHA2DS2-VASc评分（2-3或≥4）亚组筛查组检出率高于对照组，PP=0.100。强化筛查提高了检出率（7（6.93%）vs.1（0.58%），P=0.009）仅在血栓形成风险低的居民中（CHA2DS2-VaSC结论：在老年人（≥65岁）中佩戴单导联动态心电图设备可以显著提高无症状房颤的检出率。通过单次筛查，该比率随着与AF相关的危险因素的增加而显著增加。此外，同样方法的重复筛查可能只会提高低风险血栓形成评分和非AF风险因素组合组的检测率。适合不同人群的筛查方法可能需要进一步探索。
{"title":"[Screening for asymptomatic atrial fibrillation in elder community populations in Dalian: a single center study].","authors":"Y H Yang,&nbsp;R Q Xu,&nbsp;R F Zhang,&nbsp;Y S Wei,&nbsp;L Hong,&nbsp;J Sun,&nbsp;T Cong,&nbsp;Y L Xia","doi":"10.3760/cma.j.cn112148-20230819-00097","DOIUrl":"10.3760/cma.j.cn112148-20230819-00097","url":null,"abstract":"<p><p><b>Objective:</b> We aimed to determine the epidemiological characteristics of asymptomatic AF in elder community population (≥65 years old) to analyze the detection rate of different screening methods. <b>Methods:</b> The study was a prospective cohort study. The elder (≥65 years old) residents who voluntarily participated in free physical examination in Dalian community were selected. The participants were randomly divided into screening group (including intensive screening group and single screening group) and control group. The control group received interrogation, medical history collection and routine 12-lead electrocardiogram (ECG) examination. Screening group received an additional single-lead ambulatory ECG equipment worn for 5-7 days. Intensive screening group received two equal-length wearings in 2020 and 2021 respectively, while one screening group only wore once in 2020. <b>Results:</b> Finally 3 340 residents ((70.7±5.0) years old) which consisted of 1 488 males (44.55%) were enrolled. There were 1 945 residents in screening group, including 859 in intensive screening group and 1 086 in one-time screening group. The control group included 1 395 people. Detection rate of asymptomatic AF was significantly higher in screening group than control group (79(4.06%) vs. 24(1.72%), <i>P<</i>0.001). Higher detection rate was found in screening group than control group in AF risk factors (1 or 2-3) subgroups and CHA<sub>2</sub>DS<sub>2</sub>-VASc score (2-3 or≥4) subgroups (<i>P</i><0.05). Additionally, no difference was found between intensive screening group and single screening group (42(4.89%) vs. 37(3.41%), <i>P</i>=0.100). Intensive screening increased detection rate (7(6.93%) vs. 1(0.58%), <i>P</i>=0.009) only in residents those with low thrombosis risk (CHA<sub>2</sub>DS<sub>2</sub>-VaSc<2). <b>Conclusions:</b> Screening in elderly (≥65 years old) can significantly improve the detection rate of asymptomatic AF by wearing single lead dynamic ECG device. The rate increased significantly with the increase of risk factors associated with AF by single screening. In addition, repeat screening of the same method may only improve detection rates in the group with low risk thrombotic scores and non-combination of AF risk factors.Screening methods that are appropriate for different populations may require further exploration.</p>","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"51 10","pages":"1056-1062"},"PeriodicalIF":0.0,"publicationDate":"2023-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49683254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The main evolution and progress of interventional therapy for structural heart disease]. 【结构性心脏病介入治疗的主要进展和进展】。
Q3 Medicine
中华心血管病杂志
Pub Date : 2023-10-24 DOI: 10.3760/cma.j.cn112148-20230509-00262
Y J Li, Z G Zhao, Y Feng, M Chen
近年来，结构性心脏病的介入治疗发展迅猛，其范围不仅限于先天性心脏病、瓣膜性心脏病，还包括多项新兴的介入治疗技术，如左心耳封堵术、经皮心肌内室间隔射频消融术、心力衰竭的器械治疗等。我国结构性心脏病介入治疗的起步相对较晚，但随着国内相关行业专家的共同努力，近年来发展迅猛，在器械研发、技术创新等方面都取得了不少成果，部分由我国自主研发的器械和技术已经逐步走向国际。在《中华心血管病杂志》创刊50周年之际，该文通过梳理国内外相关的重磅研究和重要事件，以先天性心脏病和心脏瓣膜病的介入治疗为例，展示结构性心脏病介入治疗的主要发展历程及其最新进展。.
{"title":"[The main evolution and progress of interventional therapy for structural heart disease].","authors":"Y J Li,&nbsp;Z G Zhao,&nbsp;Y Feng,&nbsp;M Chen","doi":"10.3760/cma.j.cn112148-20230509-00262","DOIUrl":"10.3760/cma.j.cn112148-20230509-00262","url":null,"abstract":"近年来，结构性心脏病的介入治疗发展迅猛，其范围不仅限于先天性心脏病、瓣膜性心脏病，还包括多项新兴的介入治疗技术，如左心耳封堵术、经皮心肌内室间隔射频消融术、心力衰竭的器械治疗等。我国结构性心脏病介入治疗的起步相对较晚，但随着国内相关行业专家的共同努力，近年来发展迅猛，在器械研发、技术创新等方面都取得了不少成果，部分由我国自主研发的器械和技术已经逐步走向国际。在《中华心血管病杂志》创刊50周年之际，该文通过梳理国内外相关的重磅研究和重要事件，以先天性心脏病和心脏瓣膜病的介入治疗为例，展示结构性心脏病介入治疗的主要发展历程及其最新进展。.","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"51 10","pages":"1022-1027"},"PeriodicalIF":0.0,"publicationDate":"2023-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49683257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Go with heart: memories on the past 50 years of Chinese Journal of Cardiology]. 【用心走：《中华心脏病学杂志》50年回顾】。
Q3 Medicine
中华心血管病杂志
Pub Date : 2023-10-24 DOI: 10.3760/cma.j.cn112148-20230807-00059
B Yu
{"title":"[Go with heart: memories on the past 50 years of Chinese Journal of Cardiology].","authors":"B Yu","doi":"10.3760/cma.j.cn112148-20230807-00059","DOIUrl":"10.3760/cma.j.cn112148-20230807-00059","url":null,"abstract":"","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"51 10","pages":"1013-1014"},"PeriodicalIF":0.0,"publicationDate":"2023-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49683249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Single valve leaflet shedding after bi-leaflet mechanical prosthetic heart valve replacement: two case reports]. 【双瓣机械人工心脏瓣膜置换术后单瓣脱落2例报告】。
Q3 Medicine
中华心血管病杂志
Pub Date : 2023-10-24 DOI: 10.3760/cma.j.cn112148-20230809-00067
X Z Wang, J W Qiu, C F Mu, W L Zhang, C Z Xue, Y He, Q L Mu, C Y Fu, D Y Li
瓣叶脱落是人工心脏瓣膜置换术的罕见并发症。该文报道了2例双叶型人工机械心脏瓣膜置换术后单瓣叶脱落病例，并结合文献探讨了瓣叶脱落原因及处理策略。瓣叶脱落原因可能与瓣膜设计、瓣叶材质有关，需再次行瓣膜置换术。脱落瓣叶破损并严重影响远端血管者，应积极通过手术取出；未对远端血管损伤者，可暂不拆除，但需进行严密随访。.
{"title":"[Single valve leaflet shedding after bi-leaflet mechanical prosthetic heart valve replacement: two case reports].","authors":"X Z Wang,&nbsp;J W Qiu,&nbsp;C F Mu,&nbsp;W L Zhang,&nbsp;C Z Xue,&nbsp;Y He,&nbsp;Q L Mu,&nbsp;C Y Fu,&nbsp;D Y Li","doi":"10.3760/cma.j.cn112148-20230809-00067","DOIUrl":"10.3760/cma.j.cn112148-20230809-00067","url":null,"abstract":"瓣叶脱落是人工心脏瓣膜置换术的罕见并发症。该文报道了2例双叶型人工机械心脏瓣膜置换术后单瓣叶脱落病例，并结合文献探讨了瓣叶脱落原因及处理策略。瓣叶脱落原因可能与瓣膜设计、瓣叶材质有关，需再次行瓣膜置换术。脱落瓣叶破损并严重影响远端血管者，应积极通过手术取出；未对远端血管损伤者，可暂不拆除，但需进行严密随访。.","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"51 10","pages":"1080-1082"},"PeriodicalIF":0.0,"publicationDate":"2023-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49683256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Titration strategy of sacubitril/valsartan in patients with heart failure with reduced ejection fraction and hypotension]. [沙库必曲/缬沙坦在射血分数降低和低血压心力衰竭患者中的滴定策略]。
Q3 Medicine
中华心血管病杂志
Pub Date : 2023-10-24 DOI: 10.3760/cma.j.cn112148-20221222-01006
A H Wu, Z W Lin, X P Ji, H X Lyu
沙库巴曲缬沙坦作为一种新型的血管紧张素受体脑啡肽酶抑制剂，已经成为射血分数降低的心力衰竭（HFrEF）患者的一线用药，同时，沙库巴曲缬沙坦也具有降压作用，所以，目前对于合并低血压的HFrEF（HFrEF-LSBP）患者能否从沙库巴曲缬沙坦中获益存在争议。该文对低血压对沙库巴曲缬沙坦滴定的影响进行综述，并提出了HFrEF-LSBP患者中滴定沙库巴曲缬沙坦的策略，为该类患者的治疗提供参考。.
{"title":"[Titration strategy of sacubitril/valsartan in patients with heart failure with reduced ejection fraction and hypotension].","authors":"A H Wu,&nbsp;Z W Lin,&nbsp;X P Ji,&nbsp;H X Lyu","doi":"10.3760/cma.j.cn112148-20221222-01006","DOIUrl":"10.3760/cma.j.cn112148-20221222-01006","url":null,"abstract":"沙库巴曲缬沙坦作为一种新型的血管紧张素受体脑啡肽酶抑制剂，已经成为射血分数降低的心力衰竭（HFrEF）患者的一线用药，同时，沙库巴曲缬沙坦也具有降压作用，所以，目前对于合并低血压的HFrEF（HFrEF-LSBP）患者能否从沙库巴曲缬沙坦中获益存在争议。该文对低血压对沙库巴曲缬沙坦滴定的影响进行综述，并提出了HFrEF-LSBP患者中滴定沙库巴曲缬沙坦的策略，为该类患者的治疗提供参考。.","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"51 10","pages":"1098-1103"},"PeriodicalIF":0.0,"publicationDate":"2023-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49683258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
类型
全部 化学•材料 生命科学 医学 物理 工程技术 环境•农林 材料科学 地球科学 法学 管理学 化学 环境科学与生态学 计算机科学 教育学 经济学 农林科学 人文科学 生物学 数学 物理与天体物理 心理学 综合性期刊 其他 工业工程 理学 历史学 农学 文学 信息工程
数据库
全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley
期刊
中华心血管病杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
﹀
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们：info@booksci.cn
Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1